Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

Table 3

The level of serum Cys-C in BUT patients with normal GFR.

Parameters	Number of patients	Cys-C
		levels (mg/L, mean ± SD)
Age			0.001
<60 yr.	144
≥60 yr.	177
Sex			0.012
Male	263
Female	58
Smoking history			0.233
Never	204
Ever	117
Painless macroscopic hematuria			0.101
No	59
Yes	262
WBC count			0.149
<6.08 × 10^9/L	160
≥6.08 × 10^9/L	161
PLT count			0.568
<216 × 10^9/L	160
≥216 × 10^9/L	161
PFL			0.023
<2.88 g/L	161
≥2.88 g/L	160
Tumor number			0.541
Single	229
Multiple	92
Tumor size			0.619
<2 cm	101
≥2 cm	218
Pathological characteristics			0.733
Papilloma	21
PUNLMP	60
BUC	240
Grade			0.390
Low-grade	141
High-grade	99
Stage			0.913
Ta	140
T1	62
T2	27
T3	7
T4	4

Continuous variables are expressed as median . Bold values are statistically significant (). PUNLMP: papillary urothelial neoplasm of low malignant potential; BUC: bladder urothelial carcinoma; WBC: white blood cell; PLT: platelet; PFL: plasma fibrinogen levels.